age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
52.10999
|
female
| 0
| 40
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 21
| null | 44
| 546,390
| 275,272.75
| null | 24.25
|
white
| 36.195313
| 61
| 0.292969
| 0.181976
| 35
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 40
| 68
| 31.699219
| 110
| 42
| 36.39844
| 135.53125
| 2.5
| 5.399414
| 1.5
| 132
| 7.40918
| null | null | null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 1,512
| 0
|
69.66498
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 2
| 6
|
under $11k
| 0
| 9,574
| 4,297.7344
| null | 10
|
black
| 5.599609
| 20
| 0.866943
| 0.701904
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 109
| 12.5
| 70
| 20
| 36.39844
| null | 4.399414
| 0.199982
| 1.199951
| 136
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 334
| 1
|
66.409
|
female
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
>$50k
| 0
| 43,722
| 21,538.375
| null | 17
|
white
| 22.699219
| 20
| 0.825928
| 0.716919
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 11
| 66
| 7.399414
| 75
| 20
| 36.19531
| null | 2.599609
| 1.299805
| 1
| 131
| null | null | null | null | 5
| 4
|
no(M2 and SIP pres)
| 4
| 1,511
| 0
|
39.84698
|
female
| 0
| 17
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
| null | 0
| 47,588
| 22,880.9062
| null | 19
|
white
| 39.296875
| 24
| 0.20697
| 0.112991
| 3
| 0
| 0
|
metastatic
| 0.25
| 0.015625
|
no dnr
| 17
| 71
| 6.199219
| 120
| 22
| 36.39844
| null | null | null | 0.299988
| 111
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 3.707031
| 140
| 1
|
66.14099
|
male
| 1
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 16
|
>$50k
| 0
| 21,075
| 9,588.3594
| null | 11
|
white
| 22.398438
| 38
| 0.831909
| 0.724976
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
dnr after sadm
| 1
| 108
| 14.099609
| 132
| 32
| 36.59375
| 247.8125
| null | null | 1
| 137
| 7.289062
| null | null | null | null | null |
<2 mo. follow-up
| 4.05957
| 8
| 1
|
53.24597
|
male
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 26
| 231,587
| 112,461.688
| null | 45
|
white
| 39.695313
| 76
| 0.287964
| 0.177979
| 18
| 0
| 0
|
no
| 0.4
| 0.1
|
dnr after sadm
| 18
| 57
| 24.296875
| 150
| 37
| 36
| 283.625
| null | 15.599609
| 2.299805
| 142
| 7.40918
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 18
| 1
|
69.94098
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 18
|
>$50k
| 0
| 5,631
| 3,324.5644
| null | 7
|
white
| 21.898438
| 34
| 0.823975
| 0.713989
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 4
| 60
| 8
| 130
| 24
| 35.59375
| 323.75
| null | null | 1.199951
| 138
| 7.539062
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 352
| 1
|
20.69299
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
| null | 0
| 125,185
| 74,128.1875
| null | 16.5
|
white
| 28.699219
| 47
| 0.845947
| 0.792969
| 6
| 0
| 0
|
no
| 0.99
| 0.98
|
no dnr
| 11
| 120
| 16.898438
| 145
| 15
| 36.59375
| 187.75
| null | 0.599976
| 8.898438
| 134
| 7.439453
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,498
| 0
|
48.78598
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 26
| 96,189
| 48,407.3438
| null | 20
|
white
| 24.097656
| 44
| 0.770996
| 0.696899
| 3
| 1
| 0
|
no
| null | null |
no dnr
| 16
| 127
| 22.796875
| 170
| 32
| 38.29688
| 328
| null | null | 1.299805
| 153
| 7.359375
| null | null | null | null | null | null | 3.588379
| 1,495
| 0
|
35.047
|
male
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 155,711
| 74,268
| null | 38
|
other
| 37
| 66
| 0.28894
| 0.178986
| 21
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 6
| 65
| 16.398438
| 125
| 40
| 36.89844
| 237.5
| 3.099609
| 17.398438
| 2.599609
| 139
| 7.339844
| null | null | null | null | null |
<2 mo. follow-up
| 2.303223
| 6
| 1
|
72.01398
|
male
| 0
| 46
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
$25-$50k
| 0
| 173,394
| 89,319.3125
| null | 17
|
white
| 27.296875
| 40
| 0.647949
| 0.547974
| 12
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 46
| 110
| 23.296875
| 85
| 40
| 37.89844
| 140.8125
| null | null | 1.899902
| 133
| 7.55957
| null | null | null | 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 1,495
| 0
|
42.823
|
female
| 1
| 74
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 15
| null | 26
| 393,995
| 182,175.25
| null | 35.75
|
white
| 38
| 56
| 0.122986
| 0.054993
| 3
| 0
| 0
|
metastatic
| 0.5
| 0.35
|
no dnr
| 74
| 67
| 3.299805
| 130
| 50
| 39.59375
| 116.65625
| 2.5
| null | 1.5
| 149
| 7.329102
| null | null | null | null | 1
|
Coma or Intub
| 1
| 74
| 1
|
63.84097
|
female
| 0
| 9
|
Colon Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 0
| 13,525
| 7,102.8125
| null | 11
|
white
| 17.5
| 18
| 0.81189
| 0.596924
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 9
| 77
| 14.398438
| 100
| 20
| 38.19531
| null | null | 0.399963
| 0.899902
| 132
| null | null | null | null | null | null | null | 2.662598
| 380
| 1
|
62.59497
|
female
| 0
| 15
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 26
| 30,117
| 16,954.0781
| null | 11
|
white
| 17.097656
| 24
| 0.747925
| 0.602905
| 1
| 0
| 0
|
no
| 0.9
| 0.5
|
no dnr
| 15
| 82
| 7.5
| 78
| 20
| 37.79688
| 457.125
| 2
| 4.399414
| 1
| 132
| 7.519531
| null | null | null | 0
| 1
|
adl>=4 (>=5 if sur)
| 1
| 107
| 1
|
70.823
|
female
| 0
| 20
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
under $11k
| 0
| 51,017
| 26,579.4688
| null | 16.666656
|
white
| 19.097656
| 32
| 0.85498
| 0.759888
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 20
| 75
| 6.899414
| 70
| 20
| 36
| null | null | null | 2
| 141
| null | null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
| 26
| 1
|
60.758
|
female
| 0
| 11
|
Colon Cancer
|
Cancer
| 1
| 10
|
$25-$50k
| 0
| 24,158
| 12,792.6641
| null | 16
|
white
| 15.199219
| 16
| 0.846924
| 0.662964
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 11
| 117
| 11.099609
| 115
| 16
| 36.5
| null | 3.899902
| 0.699951
| 1
| 142
| null | null | null | null | null | null | null | 2.566406
| 212
| 1
|
76.03296
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 0
| 17
|
$25-$50k
| 0
| 14,594
| 7,638.6875
| null | 12
|
white
| 17.5
| 21
| 0.78894
| 0.555908
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 8
| 110
| 13.398438
| 104
| 24
| 38.59375
| null | null | null | 1.199951
| 136
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 524
| 1
|
62.42599
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 9,366
| 3,919.8184
| null | 10
|
white
| 15.5
| 9
| 0.741943
| 0.47699
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 83
| 12.798828
| 78
| 20
| 36.39844
| null | null | null | 1
| 138
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 835
| 1
|
58.58197
|
male
| 0
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 8
|
$11-$25k
| 0
| 44,079
| 24,343.4219
| null | 12
|
black
| 14.099609
| 23
| 0.828979
| 0.720947
| 11
| 0
| 0
|
no
| null | null |
no dnr
| 8
| 67
| 8.398438
| 76
| 20
| 37.89844
| null | null | null | 1.5
| 136
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 3.112793
| 168
| 1
|
38.155
|
male
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 16
|
under $11k
| 100
| 143,906
| 70,408.9375
| null | 27
|
white
| 29.898438
| 39
| 0.316956
| 0.202972
| 10
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 21
| 73
| 13.199219
| 60
| 10
| 36.59375
| 142
| 2.5
| 0.599976
| 6.5
| 131
| 7.379883
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,050
| 1
|
79.97797
|
female
| 1
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 15
| null | 26
| 214,894
| 94,687
| null | 34.75
|
white
| 38.695313
| 61
| 0.209991
| 0.11499
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 37
| 64
| 25.5
| 111
| 40
| 36.5
| 105
| null | 0.799927
| 2.399902
| 129
| 7.369141
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 37
| 1
|
72.71497
|
female
| 0
| 17
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$11-$25k
| 0
| 76,132
| 37,674.5625
| null | 10.666664
|
black
| 19.296875
| 31
| 0.845947
| 0.746948
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 17
| 105
| 7.5
| 110
| 26
| 36.5
| null | null | null | 1
| 138
| null | null | null | null | 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 1,490
| 0
|
65.53894
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 14
|
$25-$50k
| 0
| 7,769
| 3,896.7402
| null | 10
|
white
| 15.798828
| 12
| 0.730957
| 0.459961
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 125
| 9.599609
| 88
| 22
| 36.39844
| null | null | null | 0.799927
| 139
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,490
| 0
|
50.439
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 16,863
| 8,925.1484
| null | 10.5
|
black
| 32.195313
| 48
| 0.72998
| 0.645996
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
dnr after sadm
| 3
| 82
| 2.099609
| 60
| 26
| 36
| 366.625
| null | 1.299805
| 9.099609
| 130
| 7.489258
| null | null | null | 1
| null | null | 1.1669
| 178
| 1
|
61.02698
|
male
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| 13
| null | 0
| 31,943
| 16,502.6094
| null | 16.5
|
white
| 11.099609
| 38
| 0.886963
| 0.743896
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.75
|
no dnr
| 10
| 100
| 10.199219
| 128
| 28
| 38.19531
| null | 3.799805
| 2.299805
| 1.199951
| 140
| null | null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,488
| 0
|
66.37097
|
male
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| 12
|
$25-$50k
| 0
| 50,099
| 25,124.25
| null | 14.666664
|
white
| 26.5
| 42
| 0.753906
| 0.610962
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 15
| 57
| 11.599609
| 115
| 24
| 36.59375
| null | null | null | 1.599854
| 130
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,486
| 0
|
54.08899
|
female
| 1
| 9
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 23,806
| 10,995.6953
| null | 10
|
white
| 30.5
| 35
| 0.393982
| 0.099991
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 4
| 87
| 27.597656
| 128
| 30
| 36.19531
| 136.65625
| null | null | 0.799927
| 138
| 7.479492
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
75.26398
|
female
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
| null | 0
| 444,915
| 211,648.875
| null | 20.5
|
white
| 24.898438
| 41
| 0.660889
| 0.562988
| 56
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 38
| 63
| 12.5
| 115
| 40
| 36.59375
| 195
| 3.299805
| null | 1.099854
| 142
| 7.269531
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 118
| 1
|
31.72099
|
male
| 0
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 20
| null | 26
| 58,405
| 28,456.5938
| null | 18.5
|
white
| 24.699219
| 31
| 0.487
| 0.368958
| 5
| 0
| 0
|
metastatic
| null | null |
no dnr
| 10
| 73
| 7.5
| 110
| 28
| 36.29688
| 149.0625
| 2.799805
| 0.899902
| 1
| 134
| 7.449219
| null | null | null | null | 0
| null | 0
| 505
| 1
|
80.01099
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
|
$25-$50k
| 44
| 50,808
| 23,158.7031
| null | 25.5
|
white
| 19.296875
| 27
| 0.671997
| 0.576904
| 2
| 0
| 0
|
no
| 0.25
| 0.1
|
dnr after sadm
| 1
| 63
| 15.298828
| 100
| 28
| 38
| 277.75
| null | null | 1.099854
| 148
| 7.519531
| null | null | null | null | null |
<2 mo. follow-up
| 3.078613
| 45
| 1
|
83.59497
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 19
|
>$50k
| 0
| 81,350
| 38,778.9062
| null | 21
|
white
| 25.5
| 38
| 0.661987
| 0.563965
| 4
| 1
| 0
|
no
| null | null |
no dnr
| 13
| 110
| 14.699219
| 130
| 28
| 37
| 195.90625
| null | null | 1
| 133
| 7.489258
| null | null | null | 0
| 0
| null | 0
| 1,484
| 0
|
43.64697
|
female
| 0
| 59
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
>$50k
| 26
| 528,848
| 276,147.5
| null | 30.25
|
white
| 29.199219
| 38
| 0.634888
| 0.532959
| 31
| 0
| 0
|
no
| null | null |
no dnr
| 59
| 110
| 18.699219
| 110
| 8
| 36.69531
| 390
| 2.399902
| 0.699951
| 2.5
| 127
| 7.399414
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.742188
| 234
| 1
|
38.12198
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 8,624
| 5,387.1914
| null | 7
|
white
| 12.599609
| 11
| 0.828979
| 0.628906
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 76
| 4.699219
| 82
| 20
| 37.19531
| null | null | 0.299988
| 0.899902
| 138
| null | null | null | null | null | null | null | 2.130371
| 956
| 1
|
79.07495
|
female
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 7
| null | 0
| 24,141
| 13,296.5859
| null | 5
|
white
| 19
| 27
| 0.828979
| 0.720947
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 15
| 97
| 5.799805
| 76
| 20
| 36.79688
| null | null | null | 2.699707
| 139
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,482
| 0
|
84.91199
|
male
| 1
| 16
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 16
|
>$50k
| 9
| 30,383
| 15,251.25
| null | 10.333328
|
white
| 22.699219
| 30
| 0.495972
| 0.294983
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 10
| 83
| 9.199219
| 72
| 20
| 36
| null | 2.5
| null | 2.099609
| 129
| null | null | null | null | 2
| 1
|
<2 mo. follow-up
| 1
| 16
| 1
|
74.64795
|
male
| 1
| 6
|
Coma
|
Coma
| 1
| 8
|
under $11k
| 94
| 34,042
| 17,106.8125
| null | 42
|
white
| 28.199219
| 27
| 0.068985
| 0.037994
| 1
| 0
| 0
|
no
| 0.01
| 0.000001
|
dnr after sadm
| 3
| 43
| 33.195313
| 70
| 12
| 38
| 205.6875
| 3
| null | 1
| 135
| 7.469727
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 6
| 1
|
56.271
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 16
| null | 0
| 15,227
| 8,136.6094
| null | 13
|
white
| 17.597656
| 13
| 0.716919
| 0.437988
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 75
| 11.199219
| 104
| 22
| 38.19531
| 426.0625
| null | null | 0.899902
| 134
| 7.369141
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.373535
| 1,481
| 0
|
75.23096
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 20
|
$25-$50k
| 0
| 29,545
| 15,882.1641
| null | 17
|
white
| 19.097656
| 34
| 0.840942
| 0.738892
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 12
| 68
| 6.599609
| 70
| 24
| 36.69531
| null | null | null | 2.299805
| 135
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 992
| 1
|
40.53098
|
female
| 0
| 11
|
Colon Cancer
|
Cancer
| 2
| 11
|
>$50k
| 0
| 26,039
| 13,825.3984
| null | 12.5
|
hispanic
| 3.5
| 5
| 0.949951
| 0.880981
| 1
| 0
| 0
|
metastatic
| 0.98
| 0.95
|
no dnr
| 11
| 97
| 4.299805
| 70
| 14
| 37.89844
| null | 4.399414
| 1.199951
| 0.799927
| 140
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.20459
| 1,481
| 0
|
74.40094
|
male
| 1
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 15
|
>$50k
| 41
| 22,733
| 11,903.5234
| null | 32
|
white
| 24.597656
| 49
| 0.618896
| 0.432983
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 2
| 57
| 19.398438
| 50
| 26
| 38.19531
| 436.6875
| null | 0.799927
| 2.199707
| 139
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 3.560059
| 4
| 1
|
77.67596
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
|
$11-$25k
| 0
| null | null | null | 23
|
black
| 20.398438
| 23
| 0.699951
| 0.609985
| 2
| 0
| 0
|
metastatic
| null | null |
no dnr
| 12
| 85
| 11.398438
| 110
| 20
| 36.89844
| 260
| 2.5
| null | 1.199951
| 134
| 7.449219
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 59
| 1
|
68.24597
|
male
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 162,892
| 85,360.375
| null | 19.25
|
asian
| 40.296875
| 61
| 0.29895
| 0.186981
| 21
| 1
| 0
|
no
| null | null |
no dnr
| 25
| 117
| 17.898438
| 35
| 20
| 36
| 93.875
| null | 1.299805
| 4.899414
| 131
| 7.529297
| null | null | null | null | null | null | 3.179199
| 1,478
| 0
|
38.32999
|
male
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 6,062
| 4,049.2051
| null | 9
|
white
| 16.199219
| 19
| 0.91394
| 0.85498
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 113
| 8.898438
| 72
| 20
| 37
| null | null | 3.899902
| 1
| 141
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.168945
| 1,479
| 0
|
48.36697
|
male
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$11-$25k
| 26
| 74,504
| 33,867.0938
| null | 20.333328
|
white
| 19
| 24
| 0.842896
| 0.78894
| 3
| 0
| 0
|
no
| 0.98
| 0.98
|
no dnr
| 16
| 80
| 8.298828
| 115
| 28
| 39.39844
| 272.5
| 2.799805
| 0.799927
| 1.299805
| 141
| 7.509766
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.277344
| 1,477
| 0
|
80.87598
|
female
| 0
| 46
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$25-$50k
| 0
| 147,296
| 76,390.875
| null | 21.75
|
white
| 26.398438
| 43
| 0.702881
| 0.612915
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 46
| 113
| 26.199219
| 119
| 24
| 38.19531
| 177.53125
| 1.899902
| 1.599854
| 1.899902
| 135
| 7.449219
| null | null | null | null | 0
| null | 0
| 1,477
| 0
|
63.38699
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 7,253
| 3,041.6543
| null | 9
|
white
| 16.398438
| 15
| 0.7229
| 0.447998
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.15
|
no dnr
| 3
| 79
| 12.398438
| 82
| 20
| 36.39844
| null | null | null | 0.899902
| 135
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.316895
| 39
| 1
|
60.03598
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 142,731
| 62,150.5
| null | 43.5
|
white
| 31.199219
| 50
| 0.560913
| 0.448975
| 3
| 1
| 0
|
no
| null | null |
no dnr
| 10
| 60
| 13.298828
| 125
| 8
| 38.5
| 138.15625
| null | 0.799927
| 3
| 137
| 7.569336
| null | null | null | null | null |
<2 mo. follow-up
| 2.795898
| 10
| 1
|
71.45197
|
female
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 10
|
under $11k
| 0
| 29,501
| 14,482.2031
| null | 11.5
|
white
| 25.597656
| 24
| 0.75
| 0.605957
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 10
| 87
| 15.199219
| 78
| 26
| 36
| 200
| null | null | 1
| 125
| 7.299805
| null | null | null | null | 6
|
no(M2 and SIP pres)
| 6
| 1,114
| 1
|
32.95297
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 41
| 42,572
| 22,324.5938
| null | 23.5
|
white
| 33.796875
| 50
| 0.631958
| 0.529907
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 8
| 122
| 5.799805
| 110
| 45
| 39
| 194.28125
| 2.699707
| 9.298828
| 0.5
| 151
| 7.5
| null | null | null | null | null | null | 3.178711
| 1,461
| 0
|
39.63898
|
male
| 0
| 48
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 13
| null | 0
| 272,602
| 133,509.5
| null | 13.75
|
white
| 42.09375
| 59
| 0.463989
| 0.262939
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 48
| 71
| 34.398438
| 80
| 20
| 36.39844
| 404.75
| 2.5
| 29.597656
| 5.899414
| 122
| 7.30957
| null | null | null | 5
| 0
|
SIP>=30
| 0
| 1,460
| 0
|
85.11694
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 8
|
$11-$25k
| 0
| 15,112
| 7,727.9297
| null | 12
|
white
| 25.597656
| 42
| 0.626953
| 0.44397
| 1
| 0
| 0
|
yes
| 0.75
| 0.5
|
dnr after sadm
| 2
| 66
| 9.199219
| 70
| 28
| 36
| null | 3.799805
| 0.899902
| 3.199707
| 128
| null | null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 11
| 1
|
68.87299
|
female
| 1
| 3
|
Lung Cancer
|
Cancer
| 1
| 18
|
under $11k
| 41
| 9,982
| 5,144.9805
| null | 12
|
white
| 37.59375
| 47
| 0.031998
| 0
| 1
| 0
| 0
|
metastatic
| 0.05
| 0.000125
|
dnr after sadm
| 1
| 72
| 14.5
| 124
| 40
| 36.39844
| 147.5
| 2.899902
| 0.099991
| 0.399963
| 138
| 7.489258
| null | null | null | null | null |
<2 mo. follow-up
| 3.471191
| 3
| 1
|
77.13599
|
male
| 1
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 19
|
$11-$25k
| 9
| 42,561
| 21,488.2344
| null | 30
|
white
| 29.5
| 57
| 0.380981
| 0.185974
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 7
| 93
| 10.398438
| 96
| 11
| 36.19531
| 236.71875
| 2.899902
| 9
| 1.899902
| 134
| 7.509766
| null | null | null | null | null |
<2 mo. follow-up
| 3.370117
| 8
| 1
|
61.99597
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 26,184
| 13,366.4375
| null | 13.5
|
white
| 20.5
| 31
| 0.86499
| 0.776978
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 9
| 66
| 5.799805
| 70
| 26
| 36
| null | null | 1.299805
| 1.399902
| 131
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,458
| 0
|
50.97598
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 16
|
>$50k
| 0
| 93,205
| 41,622.8438
| null | 25.333328
|
white
| 28.5
| 35
| 0.790894
| 0.721924
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 8
| 138
| 14.298828
| 120
| 16
| 38.29688
| 84
| 3.599609
| 1.199951
| 1.199951
| 143
| 7.439453
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,457
| 0
|
53.45898
|
female
| 1
| 132
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 0
| 1,057,324
| 483,556.25
| null | 29.5
|
white
| 35.5
| 61
| 0.595947
| 0.487976
| 4
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 128
| 63
| 4.599609
| 75
| 24
| 36.29688
| 270
| 3.299805
| 29.699219
| 5.099609
| 137
| 7.469727
| null | null | null | null | 2
|
adl>=4 (>=5 if sur)
| 2
| 132
| 1
|
70.93994
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 20,186
| 10,203.7812
| null | 19
|
asian
| 19.699219
| 37
| 0.846924
| 0.748901
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 7
| 57
| 6.5
| 60
| 28
| 36.39844
| null | null | null | 1.299805
| 137
| null | null | null | null | 0
| 0
| null | 0
| 1,349
| 1
|
89.77399
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 5,897
| 3,399.334
| null | 6
|
white
| 18.398438
| 30
| 0.797974
| 0.674927
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 120
| 7.899414
| 104
| 27
| 36.39844
| null | null | 0.199982
| 1.199951
| 136
| null | null | null | null | 2
| null | null | 1.839
| 454
| 1
|
81.67596
|
female
| 1
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 41
| 125,968
| 60,127.875
| null | 39.333313
|
white
| 28.199219
| 39
| 0.472961
| 0.353943
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 13
| 58
| 16
| 60
| 10
| 37.19531
| 74.4375
| null | null | 0.899902
| 135
| 7.429688
| null | null | null | null | null |
<2 mo. follow-up
| 3.727539
| 16
| 1
|
59.10199
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 7
|
$25-$50k
| 0
| 34,775
| 17,118.25
| null | 18.5
|
hispanic
| 24.398438
| 45
| 0.828979
| 0.721924
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 8
| 55
| 8.099609
| 85
| 28
| 36.29688
| null | 3.199707
| 3
| 1.299805
| 134
| null | null | null | null | 2
| 2
|
<2 mo. follow-up
| 2
| 25
| 1
|
56.64099
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 20,497
| 11,364.9922
| null | 9
|
white
| 16.699219
| 22
| 0.879883
| 0.836914
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 8
| 100
| 10.099609
| 100
| 24
| 37
| 271.375
| 4.5
| 0.399963
| 0.899902
| 140
| 7.379883
| null | null | null | null | 5
|
no(M2 and SIP pres)
| 5
| 1,022
| 1
|
67.37
|
female
| 0
| 20
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 50,138
| 27,878.3281
| null | 10.333328
|
white
| 21.699219
| 36
| 0.715942
| 0.557983
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 6
| 71
| 4.399414
| 72
| 20
| 36.39844
| null | 2.599609
| 1.899902
| 4.699219
| 140
| null | null | null | null | 5
| null |
adl>=4 (>=5 if sur)
| 3.855299
| 77
| 1
|
57.46698
|
male
| 1
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$11-$25k
| 0
| 150,471
| 73,386.0625
| null | 21.25
|
asian
| 33.296875
| 41
| 0.540894
| 0.425964
| 5
| 0
| 0
|
yes
| 0.8
| 0.75
|
dnr after sadm
| 21
| 73
| 15.599609
| 120
| 16
| 36.5
| 83.67188
| null | 3.799805
| 0.799927
| 141
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 3.263672
| 33
| 1
|
68.87897
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 65,136
| 31,077.1094
| null | 21.5
|
black
| 28.097656
| 50
| 0.725952
| 0.640991
| 1
| 1
| 0
|
no
| 0.6
| 0.4
|
no dnr
| 12
| 80
| 25.898438
| 115
| 28
| 36.89844
| null | 2.199707
| 0.399963
| 2
| 129
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.728027
| 57
| 1
|
35.806
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 20,092
| 10,231.5
| null | 18
|
white
| 27.699219
| 42
| 0.863892
| 0.775879
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 50
| 8.699219
| 135
| 24
| 35.89844
| null | 3.899902
| 0.799927
| 1.599854
| 134
| null | null | null | null | null | null | null | 2.154297
| 1,448
| 0
|
35.603
|
male
| 0
| 11
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 41,788
| 20,779.6094
| null | 12.5
|
white
| 27.398438
| 25
| 0.711914
| 0.430969
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 11
| 79
| 25.597656
| 120
| 22
| 39.59375
| null | 3.099609
| 0.399963
| 0.799927
| 133
| null | null | null | null | null | null | null | 2.93457
| 814
| 1
|
43.47699
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
$11-$25k
| 26
| 79,576
| 37,880.3438
| null | 44.5
|
hispanic
| 46.695313
| 68
| 0.274963
| 0.166992
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 8
| 48
| 5.599609
| 130
| 20
| 37.5
| 130
| 2.299805
| 21.097656
| 1.399902
| 130
| 7.589844
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 11
| 1
|
58.68597
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 14
|
under $11k
| 0
| 16,964
| 9,183.4531
| null | 16
|
white
| 13.798828
| 30
| 0.924927
| 0.871948
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 7
| 57
| 10.599609
| 75
| 24
| 36.29688
| null | 4.399414
| 0.5
| 1.299805
| 132
| null | null | null | null | 0
| 0
| null | 0
| 1,446
| 0
|
44.60797
|
female
| 1
| 9
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 8
|
under $11k
| 41
| 214,817
| 115,186
| null | 20
|
hispanic
| 25.296875
| 36
| 0.546997
| 0.348999
| 58
| 0
| 0
|
no
| 0.2
| 0.05
|
dnr after sadm
| 5
| 120
| 12.398438
| 115
| 12
| 38.29688
| 280
| null | 9.599609
| 0.799927
| 137
| 7.489258
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 9
| 1
|
70.04797
|
male
| 0
| 14
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$25-$50k
| 0
| 26,738
| 14,451.3594
| null | 10
|
white
| 14.5
| 36
| 0.815918
| 0.700928
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 14
| 63
| 6.299805
| 74
| 20
| 36.39844
| 266.625
| 1.599854
| 1.099854
| 1.199951
| 135
| 7.529297
| null | null | null | null | 1
| null | 1
| 1,445
| 0
|
45.043
|
female
| 1
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
| null | 44
| 194,716
| 93,609.625
| null | 31
|
white
| 35.796875
| 74
| 0.461975
| 0.342957
| 2
| 0
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 12
| 128
| 0.299988
| 115
| 38
| 36
| 250
| 2.199707
| 0.699951
| 2.199707
| 148
| 7.469727
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 22
| 1
|
60.79398
|
female
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
| null | 26
| 141,714
| 67,726.3125
| null | 31.333328
|
white
| 29.296875
| 55
| 0.556885
| 0.444946
| 10
| 0
| 0
|
no
| null | null |
no dnr
| 20
| 59
| 12.898438
| 155
| 28
| 38.59375
| 119.98438
| null | 1.199951
| 0.899902
| 137
| 7.5
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 136
| 1
|
55.88199
|
female
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 14
|
under $11k
| 0
| 6,593
| 2,757.2383
| null | 9
|
black
| 13.798828
| 5
| 0.783936
| 0.545898
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.75
|
dnr after sadm
| 1
| 94
| 8
| 88
| 20
| 37
| null | null | null | 1
| 138
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.224121
| 574
| 1
|
65.02899
|
female
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 3,087
| 2,025.5361
| null | 7
|
black
| 24.398438
| 35
| 0.707886
| 0.547974
| 1
| 1
| 0
|
metastatic
| 1
| 0.3
|
no dnr
| 3
| 103
| null | 68
| 26
| 35.79688
| 471.375
| null | null | 1.5
| 126
| 7.5
| null | null | null | 2
| 6
|
<2 mo. follow-up
| 6
| 35
| 1
|
19.17
|
female
| 0
| 30
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 166,750
| 79,628.75
| null | 29.25
|
hispanic
| 50.296875
| 86
| 0.44696
| 0.245972
| 1
| 0
| 0
|
yes
| 0.5
| 0.1
|
no dnr
| 30
| 46
| 16.199219
| 170
| 47
| 36
| 31.66406
| null | null | 1.599854
| 131
| 7.189453
| null | null | null | null | null | null | 2.340332
| 1,440
| 0
|
72.84296
|
female
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 26
| 196,869
| 94,460.75
| null | 50.5
|
white
| 33
| 38
| 0.35199
| 0.234985
| 16
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 50
| 10.199219
| 120
| 10
| 36.79688
| 188
| 3
| null | 1
| 127
| 7.489258
| null | null | null | null | null |
<2 mo. follow-up
| 2.65625
| 11
| 1
|
42.03699
|
male
| 1
| 28
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 20
|
>$50k
| 0
| 100,295
| 48,086.9375
| null | 16.25
|
white
| 29.796875
| 59
| 0.738892
| 0.589966
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 28
| 77
| 6.799805
| 82
| 20
| 36.39844
| null | 1.399902
| 17.296875
| 2
| 128
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
59.806
|
female
| 0
| 21
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$25-$50k
| 26
| 75,895
| 34,792.25
| null | 15.333328
|
asian
| 23.597656
| 32
| 0.721924
| 0.566895
| 2
| 0
| 0
|
yes
| 0.6
| 0.4
|
no dnr
| 21
| 128
| 13.699219
| 145
| 26
| 37
| 222.84375
| null | null | 0.699951
| 143
| 7.349609
| null | null | null | null | 0
| null | 0
| 1,437
| 0
|
49.56097
|
male
| 1
| 32
|
Coma
|
Coma
| 1
| 16
|
>$50k
| 44
| 245,849
| 101,754.438
| null | 36.5
|
black
| 30
| 50
| 0.355957
| 0.282959
| 17
| 1
| 0
|
no
| null | null |
dnr after sadm
| 13
| 102
| 22.398438
| 100
| 12
| 38.29688
| 154
| null | 2.099609
| 2.199707
| 129
| 7.539062
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 32
| 1
|
51.93997
|
male
| 0
| 39
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
under $11k
| 37
| 280,893
| null | null | 32
|
white
| 28.699219
| 42
| 0.359985
| 0.241974
| 5
| 0
| 0
|
yes
| 0.5
| 0.4
|
dnr after sadm
| 9
| 63
| 5.699219
| 110
| 18
| 39.19531
| 172
| null | 3.299805
| 2.099609
| 140
| 7.459961
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,072
| 1
|
55.24698
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 6,536
| 3,746.0566
| null | 7
|
white
| 15
| 16
| 0.922974
| 0.869995
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 4
| 87
| 9.199219
| 84
| 20
| 36
| 257.125
| null | 0.5
| 1.199951
| 140
| 7.509766
| null | null | null | 2
| null | null | 1.839
| 235
| 1
|
73.75494
|
male
| 0
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 44
| 29,426
| 13,739.3125
| null | 23
|
black
| 34.398438
| 68
| 0.121994
| 0.053993
| 1
| 1
| 0
|
metastatic
| 0.05
| 0.000125
|
dnr after sadm
| 1
| 50
| 17.398438
| 104
| 28
| 38.39844
| 158.3125
| 2
| 0.5
| 2.099609
| 153
| 7.199219
| null | null | null | null | null |
<2 mo. follow-up
| 3.889648
| 35
| 1
|
47.93198
|
female
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 3
| null | null | 0
| 92,238
| 45,525.5312
| null | 45
|
white
| 46.296875
| 83
| 0.026997
| 0.007
| 21
| 0
| 0
|
metastatic
| 0.2
| 0.1
|
dnr after sadm
| 4
| 60
| 0.049995
| 150
| 40
| 36.29688
| 167.34375
| 2.599609
| 2.199707
| 2.899902
| 129
| 7.399414
| null | null | null | null | null |
<2 mo. follow-up
| 3.251953
| 5
| 1
|
58.69699
|
female
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 6,849
| 3,490.2266
| null | 4
|
hispanic
| 19.398438
| 40
| 0.883911
| 0.806885
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 3
| 100
| 5.899414
| 80
| 28
| 36.59375
| 352.375
| null | null | 2.199707
| 138
| 7.40918
| null | null | null | null | null |
SIP>=30
| 2.371582
| 1,086
| 1
|
60.73099
|
male
| 0
| 50
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
| null | 26
| 363,112
| 186,497.75
| null | 28.75
|
hispanic
| 25.398438
| 56
| 0.642944
| 0.541992
| 15
| 0
| 0
|
no
| null | null |
no dnr
| 50
| 107
| 8.099609
| 70
| 24
| 36.29688
| 315
| 2.799805
| 11.898438
| 8.199219
| 142
| 7.469727
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,434
| 0
|
68.50397
|
male
| 0
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 16
|
>$50k
| 9
| 41,674
| 19,016.3594
| null | 23
|
white
| 23.296875
| 32
| 0.652954
| 0.553955
| 2
| 0
| 0
|
yes
| 0.7
| 0.6
|
no dnr
| 9
| 69
| 3
| 70
| 26
| 38.19531
| 231.40625
| null | 2.399902
| 1.199951
| 131
| 7.459961
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 338
| 1
|
41.75497
|
female
| 1
| 6
|
Coma
|
Coma
| 6
| 16
|
>$50k
| 100
| 69,323
| 33,539.1875
| null | 36
|
white
| 42.09375
| 60
| 0.016998
| 0.007
| 3
| 1
| 0
|
no
| null | null |
dnr after sadm
| 6
| 40
| 31.597656
| 120
| 26
| 38.59375
| 260
| null | null | 3.799805
| 146
| 7.599609
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 6
| 1
|
48.14798
|
male
| 0
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 23,166
| 11,004.8984
| null | 11
|
white
| 23.898438
| 9
| 0.846924
| 0.793945
| 2
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 4
| 78
| 14.099609
| 82
| 18
| 36.79688
| 86
| null | 0.699951
| 1
| 138
| 7.40918
| null | null | null | null | null | null | 2.194824
| 1,432
| 0
|
48.564
|
male
| 0
| 44
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 19
| null | 0
| 225,659
| 108,896.062
| null | 20
|
white
| 31.199219
| 49
| 0.437988
| 0.317993
| 18
| 0
| 0
|
yes
| null | null |
no dnr
| 44
| 103
| 0.099991
| 110
| 20
| 39.5
| 208.15625
| 2
| null | 1.399902
| 131
| 7.509766
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 181
| 1
|
45.51398
|
male
| 1
| 39
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 16
|
>$50k
| 0
| 323,371
| 183,641.75
| null | 7
|
asian
| 27.597656
| 46
| 0.754883
| 0.611938
| 1
| 0
| 0
|
no
| 0.8
| 0.4
|
dnr after sadm
| 39
| 94
| 9.199219
| 82
| 18
| 36.19531
| null | 1.899902
| 11.199219
| 1.399902
| 126
| null | null | null | null | 0
| 1
|
<2 mo. follow-up
| 1
| 39
| 1
|
82.66699
|
female
| 0
| 27
|
Coma
|
Coma
| 3
| 12
|
under $11k
| 55
| 130,916
| 66,110.1875
| null | 18.75
|
white
| 26.597656
| 23
| 0.072998
| 0.040993
| 5
| 0
| 1
|
yes
| 0.2
| 0.2
|
dnr after sadm
| 3
| 112
| 79.1875
| 55
| 18
| 38.5
| 212.5
| null | null | 0.699951
| 125
| 7.519531
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 128
| 1
|
42.45599
|
male
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
|
>$50k
| 26
| 63,445
| 31,127.625
| null | 16.666656
|
hispanic
| 18
| 30
| 0.868896
| 0.822998
| 3
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 20
| 113
| 9.199219
| 110
| 33
| 38.29688
| 220
| null | 0.299988
| 0.799927
| 137
| 7.469727
| null | null | null | null | 0
|
SIP>=30
| 0
| 1,430
| 0
|
70.20898
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 9,088
| 4,997.6172
| null | 10
|
white
| 15.199219
| 15
| 0.731934
| 0.460999
| 1
| 0
| 0
|
metastatic
| 0.65
| 0.5
|
no dnr
| 6
| 111
| 12.199219
| 80
| 22
| 36.59375
| null | null | null | 1
| 137
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 452
| 1
|
40.39999
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 3
| null | null | 0
| 12,693
| 5,611.8125
| null | 11
|
white
| 17
| 6
| 0.761963
| 0.509888
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 4
| 90
| 6.299805
| 104
| 18
| 36.59375
| null | null | null | 0.899902
| 139
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.730957
| 130
| 1
|
76.08997
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 8
| null | 0
| 12,254
| 6,517.3008
| null | 8
|
white
| 22.097656
| 19
| 0.797974
| 0.674927
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 7
| 80
| 14
| 120
| 20
| 36.19531
| 260
| null | null | 0.799927
| 142
| 7.449219
| null | null | null | 6
| null | null | 4.527397
| 240
| 1
|
77.85895
|
female
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 89,858
| 41,205.5625
| null | 39
|
white
| 28.699219
| 76
| 0.338989
| 0.222992
| 3
| 0
| 0
|
metastatic
| 0.25
| 0.05
|
dnr before sadm
| -1
| 58
| 8.699219
| 165
| 16
| 38.79688
| 91.10938
| 1.699951
| 0.899902
| 1.5
| 143
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 3.657227
| 8
| 1
|
71.02295
|
male
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
| null | 0
| 132,772
| 59,345.3438
| null | 30.666656
|
white
| 29.199219
| 50
| 0.620972
| 0.515991
| 8
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 13
| 110
| 10.298828
| 140
| 23
| 38.19531
| 126.3125
| null | 2
| 1.799805
| 137
| 7.349609
| null | null | null | null | null |
<2 mo. follow-up
| 2.482422
| 14
| 1
|
30.35999
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 37
| 283,773
| 137,584.625
| null | 44.5
|
black
| 29.699219
| 38
| 0.667969
| 0.570923
| 13
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 12
| 100
| 17
| 115
| 10
| 37.79688
| 332.5
| 2.199707
| 27.398438
| 1
| 136
| 7.389648
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,425
| 0
|
76.74194
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 12
| null | 0
| 14,066
| 7,114.2422
| null | 14
|
white
| 18.097656
| 38
| 0.8479
| 0.75
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 5
| 58
| 7.799805
| 70
| 20
| 36.5
| null | null | null | 1.599854
| 135
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.955078
| 349
| 1
|
76.97198
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 13
|
>$50k
| 0
| 11,489
| 6,593.7188
| null | 10
|
black
| 18.296875
| 21
| 0.844971
| 0.744995
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 85
| 4.699219
| 100
| 20
| 36.5
| 352.375
| null | null | 1.599854
| 139
| 7.449219
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,424
| 0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.